• menu
    Market Place Market Place
    Sourcing support Sourcing Support
    API / FDF
    Excipients
    Services
    Developments
    News
    Market Intel
    #Phispers
    #SpeakPharma
    #LearnMore

    NEWS

    DRUGS & DEVELOPMENTS

    MARKET INTEL by PharmaCompass

    DRL offers a portfolio of products & services, including APIs, CMO services, generics, biosimilars & differentiated formulations.

    Biogen Completes Acquisition of HI-Bio

    CONTRACT PHARMA

    Hi-Bio Felzartamab Kidney Rejection: Positive Phase 2 Results In Recipients

    PR NEWSWIRE

    Hi-Bio Felzartamab Igan Positive: Phase 2 Ignaz Interim Results At Era

    PR NEWSWIRE

    Biogen in up to $1.8 bln deal as rare diseases take center stage

    REUTERS

    HI-Bio to Present at the 61st European Renal Association (ERA) Congress

    PR NEWSWIRE

    HI-Bio Receives FDA Orphan Designation for Felzartamab for in Kidney Transplant

    PR NEWSWIRE

    HI-Bio Announces $95 Million Series B Financing

    PR NEWSWIRE

    HI-Bio raises $95M as it pushes toward late-stage studies

    ENDPTS

    HI-Bio Announces Felzartamab Granted Breakthrough Therapy Designation

    PR NEWSWIRE

    HI-Bio Initiates Healthy Volunteer Study of HIB210 for Immune-Mediated Diseases

    PR NEWSWIRE

    HI-Bio Receives FDA Orphan Drug Designation for Felzartamab

    PR NEWSWIRE

    HI-Bio Announces Positive Phase 2 Data on Felzartamab for Membranous Nephropathy

    PR NEWSWIRE

    Copyright © 2024 LePro PharmaCompass OPC Private Limited, All rights reserved.